BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35063629)

  • 21. C1-esterase inhibitor for short-term prophylaxis in a patient with hereditary angioedema with normal C1 inhibitor function.
    Yu SK; Callum J; Alam A
    J Clin Anesth; 2016 Dec; 35():488-491. PubMed ID: 27871580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.
    Moldovan D; Bernstein JA; Hakl R; Porebski G; Poarch K; Lumry WR; Relan A
    J Allergy Clin Immunol Pract; 2019; 7(8):2938-2940. PubMed ID: 31170541
    [No Abstract]   [Full Text] [Related]  

  • 23. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
    Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful perinatal management of hereditary angioedema with normal C1 esterase inhibitor and factor XII mutation using C1 esterase inhibitor therapy.
    Gibbons KR; Abraham T; Sandhu M; Peppers BP; Girzhel JF; Hostoffer RW
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):558-559. PubMed ID: 29017903
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orladeyo (Berotralstat): A Novel Oral Therapy for the Prevention of Hereditary Angioedema.
    Powell J; Piszczatoski C; Rubido E
    Ann Pharmacother; 2022 Apr; 56(4):488-493. PubMed ID: 34282650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant C1 esterase inhibitor (Ruconest) for hereditary angioedema.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):e44-5. PubMed ID: 27027690
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
    Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema.
    Schlueter M; Nestler-Parr S
    J Comp Eff Res; 2024 May; 13(5):e230165. PubMed ID: 38545965
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
    Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency.
    Moldovan D; Bernstein JA; Cicardi M
    Immunotherapy; 2015; 7(7):739-52. PubMed ID: 26250409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
    Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
    Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.
    Ohsawa I; Honda D; Suzuki Y; Fukuda T; Kohga K; Morita E; Moriwaki S; Ishikawa O; Sasaki Y; Tago M; Chittick G; Cornpropst M; Murray SC; Dobo SM; Nagy E; Van Dyke S; Reese L; Best JM; Iocca H; Collis P; Sheridan WP; Hide M
    Allergy; 2021 Jun; 76(6):1789-1799. PubMed ID: 33247955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema.
    Feussner A; Kalina U; Hofmann P; Machnig T; Henkel G
    Transfusion; 2014 Oct; 54(10):2566-73. PubMed ID: 24805006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful C1 inhibitor short-term prophylaxis during redo mitral valve replacement in a patient with hereditary angioedema.
    Bernstein JA; Coleman S; Bonnin AJ
    J Cardiothorac Surg; 2010 Oct; 5():86. PubMed ID: 20955596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cost-effective algorithm for diagnosis of hereditary angioedema with normal C1 inhibitor: Applying molecular approach to clinical practice.
    Dias MM; Moreno AS; Maia LSM; Nunes FL; Campos WN; Ferriani MPL; Silva WA; Arruda LK
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):419-421.e4. PubMed ID: 31319218
    [No Abstract]   [Full Text] [Related]  

  • 38. Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center.
    Srinivasan C; Ritchie B; Adatia A
    Front Immunol; 2024; 15():1339421. PubMed ID: 38318176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
    Gandhi PK; Gentry WM; Bottorff MB
    Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience.
    Baynova K; Cimbollek S; Quiralte J; García R; Lucena JM; Lasa Luaces E; Lara Jiménez MA; Alvarez Nieto J; Moreto J; González-Quevedo T
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):198-199. PubMed ID: 37796634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.